[1] Shi JF, Belinson JL, Zhao FH,et al. Human papillomavirus testing for cervical cancer screening: results from a 6-year prospective study in rural China[J].Am J Epidemiol,2009, 170(6): 708-716. [2] Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J].CA Cancer J Clin,2016,66(2): 115-132. [3] Bornstein J, Bentley J, B sze P, et al. 2011 colposcopic terminology of the International Federation for Cervical Pathology and Colposcopy[J].Obstet Gynecol,2012, 120(1): 166-172. [4] 钱德英. 阴道镜下异常图像对宫颈病变筛查意义[J].中国实用妇科与产科杂志,2016, 32(5): 399-402. [5] 周晖, 卢淮武, 彭永排, 等. 《2015年NCCN宫颈癌临床实践指南》解读[J].中国实用妇科与产科杂志, 2015, 31(3): 185-191. [6] Landy R, Pesola F, Casta ón A, et al. Impact of cervical screening on cervical cancer mortality: estimation using stage-specific results from a nested case-control study[J].Br J Cancer,2016,115(9): 1140-1146. [7] Belinson SE, Belinson JL. Human papillomavirus DNA testing for cervical cancer screening: practical aspects in developing countries[J].Mol Diagn Ther,2010, 14(4): 215-222. [8] Guo F, Liu Y, Wang X, et al. Human papillomavirus infection and esophageal squamous cell carcinoma: a case-control study[J].Cancer Epidemiol Biomarkers Prev,2012, 21(5): 780-785. [9] Colgan TJ. Programmatic assessments of the clinical effectiveness of gynecologic liquid-based cytology[J].Cancer,2003, 99(5): 259-262. [10] Costa MO, Heráclio SA, Coelho AV, et al. Comparison of conventional Papanicolaou cytology samples with liquid-based cervical cytology samples from women in Pernambuco, Brazil[J].Braz J Med Biol Res,2015, 48(9): 831-838. [11] 钱德英,岑坚,王丁,等.高危型人乳央状瘤病毒DNA检测与细胞学联合检查对子宫顼癌前病变筛查的研究[J].中华妇产科杂志, 2006. 41(1): 34-37. [12] 劳芝英. HPV、TCT及阴道镜对宫颈癌筛查的意义[J].实用癌症杂志,2014,30(7): 826-828. [13] 李秀, 杨姗姗, 安然. 宫颈液基薄层细胞学检测(TCT)联合阴道镜在筛查宫颈癌前病变中的价值[J].中国实验诊断学,2013,17 (9): 1644-1647.
2018, Vol. 35 
